China Universal Asset Management Co., Ltd. - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26
+36.8%
1,782
+97.6%
0.01%
+33.3%
Q2 2023$19
-5.0%
902
-2.8%
0.01%
-14.3%
Q1 2023$20
+25.0%
928
+51.6%
0.01%
+16.7%
Q4 2022$16
-99.9%
612
+15.5%
0.01%
+20.0%
Q3 2022$13,0005300.01%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Kynam Capital Management, LP 956,165$20,930,00011.19%
Aisling Capital Management LP 1,025,000$22,437,0007.92%
FRAZIER MANAGEMENT LLC 2,772,062$60,680,0004.67%
SPHERA FUNDS MANAGEMENT LTD. 1,176,585$25,755,0002.83%
Paradigm Biocapital Advisors LP 453,091$9,918,0002.83%
Ghost Tree Capital, LLC 300,000$6,567,0002.35%
Avidity Partners Management LP 4,823,400$105,584,0002.24%
Nantahala Capital Management 2,850,559$62,399,0002.20%
ACUTA CAPITAL PARTNERS, LLC 206,126$4,512,0001.90%
BVF INC/IL 2,099,714$45,963,0001.67%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders